Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy
<p>Abstract</p> <p>Background</p> <p>The administration of rituximab (RTX) <it>in vivo </it>results in B-cell depletion, but evidence for multiple mechanisms of action have been reported. Surprisingly, B cell depletion produced a response in patients with po...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-07-01
|
| Series: | BMC Musculoskeletal Disorders |
| Online Access: | http://www.biomedcentral.com/1471-2474/11/157 |